# Robin Mukherjee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robin-mukherjee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,888 |
| Field | Hormonal Regulation and Hypertension |
| h-index | 11 |
| i10-index | 11 |
| Last Known Institution | DBV Technologies (France) |
| OpenAlex ID | https://openalex.org/A5059242809 |
| Works | 28 |

## Researcher papers

- [Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes](https://scholariq.org/papers/early-intensive-vs-a-delayed-conservative-simvastatin-strategy-in-patients-with/)
- [Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes](https://scholariq.org/papers/selective-aldosterone-blockade-with-eplerenone-reduces-albuminuria-in-patients/)
- [Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure](https://scholariq.org/papers/eplerenone-reduces-mortality-30-days-after-randomization-following-acute/)
- [Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)](https://scholariq.org/papers/serum-potassium-and-clinical-outcomes-in-the-eplerenone-post-acute-myocardial/)
- [Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study](https://scholariq.org/papers/randomized-double-blind-safety-study-of-enoxaparin-versus-unfractionated-heparin/)
- [Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Aldosterone Antagonism With Eplerenone on Ventricular Remodeling in Patients With Mild-to-Moderate Heart Failure and Left Ventricular Systolic Dysfunction](https://scholariq.org/papers/randomized-double-blind-multicenter-placebo-controlled-study-evaluating-the/)
- [A pilot study of rhuIL-11 treatment of refractory ITP](https://scholariq.org/papers/a-pilot-study-of-rhuil-11-treatment-of-refractory-itp/)
- [Evaluation of Eplerenone in the Subgroup of EPHESUS Patients with Baseline Left Ventricular Ejection Fraction ≤30%](https://scholariq.org/papers/evaluation-of-eplerenone-in-the-subgroup-of-ephesus-patients-with-baseline-left/)
- [Combination Angiotensin Receptor Blocker/Hydrochlorothiazide as Initial Therapy in the Treatment of Patients With Severe Hypertension](https://scholariq.org/papers/combination-angiotensin-receptor-blocker-hydrochlorothiazide-as-initial-therapy/)
- [A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress](https://scholariq.org/papers/a-randomized-clinical-trial-comparing-the-effect-of-basal-insulin-and-inhaled/)

## Researcher topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Adrenal Hormones and Disorders](https://scholariq.org/topics/adrenal-hormones-and-disorders/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [DBV Technologies (France)](https://scholariq.org/institutions/dbv-technologies-france/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.